Insights Into Acute Lymphoblastic Leukemia (ALL) 2023
Perspectives of community physicians on the treatment of ALL
Northwest – March 6, 2023
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
Southeast – March 7, 2023
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
Midwest – August 21, 2023
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
More Information
- Virtual series
- Northern California, Oregon, Washington, Idaho, Montana, Wyoming
More Information
- Virtual series
- Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia
More Information
- Virtual series
- Illinois, Iowa, Minnesota, Nebraska, North Dakota, South Dakota, Wisconsin, Michigan, Indiana, Ohio
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on the treatment of ALL
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies will be obtained: blinatumomab, ponatinib, inotuzumab ozogamicin, liposomal vincristine, and chimeric antigen receptor (CAR) T-cell therapy
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprises 10–15 medical oncologists representative of each region
